Table 1.
Demographics and clinical characteristics of the study population
| Characteristics | Value |
| Female gender, n (%) (n = 52) | 35 (67.3) |
| Mean age at EUS-FNA, y, mean ± SD (interval) | 59.1 ± 14.8 (29-91) |
| Cyst location, n (%) (n = 52) | |
| Head | 22 (42.3) |
| Body | 20 (38.5) |
| Tail | 9 (17.3) |
| Multiple cyst locations | 1 (1.9) |
| Cyst size, cm, mean ± SD (interval) | 3.9 ± 2.3 (1-10) |
| Cyst size > 3 cm, n (%) | 29 (55.8) |
| Cyst with nodule/mass, n (%) | 18 (34.6) |
| EUS imaging, n (%) (n = 52)1 | |
| No high risk features | 13 (25) |
| 1 high risk feature | 29 (55.8) |
| ≥ 2 risk features | 10 (19.2) |
| PCF CEA, n (%) (n = 52) | |
| CEA < 192 ng/mL | 31 (59.6) |
| CEA ≥ 192 ng/mL | 17 (32.7) |
| No result available | 4 (7.7) |
| PCF cytology, n (%) (n = 52) | |
| Non-diagnostic | 27 (51.9) |
| Negative for malignancy | 14 (26.9) |
| Suspicious/malignant | 10 (19.2) |
| NET | 1 (2) |
| Treatment decision, n (%) (n = 52) | |
| Follow up | 34 (65.4) |
| Surgery | 11 (21.2) |
| Endoscopic drainage | 1 (1.9) |
| Palliation (symptomatic or chemotherapy) | 6 (11.5) |
1
High-risk features: cyst size ≥ 3 and solid component or thick wall or dilated Wirsung (> 10 mm). CEA: Carcinoembryonic antigen; EUS-FNA: Endoscopic ultrasound with fine needle aspiration; NET: Neuroendocrine tumor; PCF: Pancreatic cyst fluid; SD: standard deviation.